Clinical Trial: A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled IR199 in Patients With Gastric Cancer and Pancreatic Cancer

U.S., July 17 -- ClinicalTrials.gov registry received information related to the study (NCT07707531) titled 'A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled IR199 in Patients With Gastric Cancer and Pancreatic Cancer' on June 29.

Brief Summary: This study is to evaluate the safety, biodistribution, radiation dosimetry and tumor uptake of the [68Ga]/ [131I]-IR199 in patients with Claudin 18.2 positive gastric cancer and pancreatic cancer.

Study Start Date: June 01

Study Type: INTERVENTIONAL

Condition: Gastric Cancer Pancreatic Cancer

Intervention: DRUG: [68Ga]/ [131I]-IR199

[68Ga]/ [131I]-IR199, single dose

Recruitment Status: RECRUITING

Sponsor: Huashan Hospital

Information provided by (Res...